Referred to the House Committee on Ways and Means.
This bill amends Internal Revenue Code section 213(d)(1) to classify private umbilical cord blood and cord tissue banking services as medical care expenses. Eligible services must be provided by an accredited bank complying with regulations under section 361 of the Public Health Service Act.
Whether tax benefit is equitable or primarily aids wealthier families
Relative to its intended legislative type, this bill is a narrowly scoped, straightforward statutory amendment that clearly accomplishes its primary objective of adding private umbilical cord blood or cord tissue banking services to IRC section 213(d)(1) as medical care expenses, with an explicit effective date and linkage to existing PHS Act regulatory requirements.
This bill amends Internal Revenue Code section 213(d)(1) to classify private umbilical cord blood and cord tissue banking services as medical care expenses.
Eligible services must be provided by an accredited bank complying with regulations under section 361 of the Public Health Service Act.
The change applies to taxable years beginning after December 31, 2024.
Technically narrow and administrable but creates a tax expenditure; more likely as part of a larger tax or budget bill than as standalone legislation.
Relative to its intended legislative type, this bill is a narrowly scoped, straightforward statutory amendment that clearly accomplishes its primary objective of adding private umbilical cord blood or cord tissue banking services to IRC section 213(d)(1) as medical care expenses, with an explicit effective date and linkage to existing PHS Act regulatory requirements.
Whether tax benefit is equitable or primarily aids wealthier families
These are examples from the analysis, not a ranked list of the most-affected groups.
Whether tax benefit is equitable or primarily aids wealthier families
Likely skeptical: approves increased access to certain medical services but worries this mainly subsidizes private industry over public health.
Concern that tax benefits disproportionately help wealthier families and may weaken public cord-bank supplies.
Viewed as a modest, technical tax change expanding allowable medical expenses while attaching safety requirements.
Supportive if fiscal effects are small and public bank impacts are mitigated.
Generally favorable: seen as parental choice and tax relief that supports private-sector solutions, with accreditation language reassuring on safety.
Prefers minimizing regulation but accepts accreditation requirement.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Technically narrow and administrable but creates a tax expenditure; more likely as part of a larger tax or budget bill than as standalone legislation.
The bill has not accumulated any surfaced votes yet.
Whether tax benefit is equitable or primarily aids wealthier families
Technically narrow and administrable but creates a tax expenditure; more likely as part of a larger tax or budget bill than as standalone l…
Relative to its intended legislative type, this bill is a narrowly scoped, straightforward statutory amendment that clearly accomplishes its primary objective of adding private umbilical cord blood or cord tissue bankin…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.